Sign in
CompletedNo phase

Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

Key facts

Who runs it
Humanity and Health Research Centre
Where
China and Japan3 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
1,210 people enrolled
Started
15 May 2015
Ended
31 Jul 2024
Type of study
Observational
Record updated
24 March 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients with chronic hepatitis C treated with interferon-based therapy or direct-acting agents (DAAs)-based regimen
  • Provide written, informed consent
  • Be willing and able to comply with the visit schedule and protocol-mandated procedures

Who cannot take part

  • Individuals planning to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up time frame
  • History of clinically significant illness or any other major medical disorder that may interfere with follow up, assessments, or compliance with the protocol
  • Inability to provide written informed consent

Where is this trial?

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The study is designed to provide long term clinical and virologic follow up in subjects infected with hepatitis C virus (HCV) who received interferon-based therapy or direct-acting antiviral agents (DAAs)-based therapy. This long term follow up study is observational and no treatment is provided for HCV infection.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Long Term Follow-up for Subjects With Chronic Hepatitis C Infection Who Received Interferon-based Therapy or Direct-acting Antiviral Agents (DAAs)-Based Therapy
Record updated
24 March 2025